Hudson Bay Capital Management LP Burning Rock Biotech LTD Transaction History

Hudson Bay Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.75 - $10.44 $233,598 - $1.39 Million	-133,485 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.7 - $10.23 $1.12 Million - $1.71 Million	-167,576 Reduced 55.66%	133,485 $1.24 Million
Q1 2021 May 14, 2021	SELL	$23.5 - $39.58 $8.05 Million - $13.6 Million	-342,627 Reduced 53.23%	301,061 $8.11 Million
Q4 2020 Feb 12, 2021	BUY	$22.55 - $30.87 $1.24 Million - $1.7 Million	55,000 Added 9.34%	643,688 $14.9 Million
Q3 2020 Nov 12, 2020	BUY	$19.07 - $29.61 $979,759 - $1.52 Million	51,377 Added 9.56%	588,688 $14.8 Million
Q2 2020 Aug 12, 2020	BUY	$23.21 - $31.43 $12.5 Million - $16.9 Million	537,311 New	537,311 $14.5 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $589M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.